An independent guide to cash-pay care. Every price is dated and sourced.

How we check

PeRx peptides review: is it legit?

PeRx is a real telehealth brand of Wellness MD Group PC, but we rate it Avoid because it sells BPC-157 at $229 a month along with TB-500, CJC-1295/ipamorelin and thymosin alpha-1, peptides that FDA's lists do not allow a pharmacy to compound [4].

Bottom line: Rated Avoid; Compounded GLP-1s $249 to $399/mo.

None of them is on the 503A bulks list or in Category 1 [2]. We found no FDA warning letter to PeRx as of Oct 24, 2026 [9].

PeRx is a US telehealth service, run as Wellness MD Group PC DBA PeRx, that prescribes compounded peptides and compounded GLP-1s after an online consultation [1].

Our verdict

Avoid

Prescription-only and clear that its products are not FDA-approved, but most of its peptide menu cannot be legally compounded today. We do not link to it.

What checks out

  • Requires a prescription after an online consult [1].
  • States that its peptides are not FDA-approved [4].
  • No consult, membership or shipping fee listed [3].

What to watch

  • Sells many peptides that FDA's lists do not allow a 503A pharmacy to compound [1] [2].
  • Does not name its pharmacy or give a street address [4].
  • Peptide billing is described two ways on one page, per vial and per month [3].
FDA record
No warning letter found in FDA's database or in web searches of fda.gov, Oct 24, 2026.
BBB
Not checked. bbb.org blocks automated access.
Best for
No one, while it sells peptides that cannot be legally compounded.

Check a peptide's FDA status

FDA warning letter
None foundFDA database, Oct 24, 2026 [9]
Company
Wellness MD Group PCFooter of its site [4]
Pharmacy
Not namedSays a 503A pharmacy in its network [4]
BBB
Not checkedbbb.org blocks automated access

Is PeRx legit?

PeRx exists and operates as a prescriber, not a research-chemical shop. Its site says prescriptions are issued only after an online consultation with an independent licensed provider, and it does not use "research use" labels [1]. It says compounded medications are not FDA-approved and that FDA does not review them for safety or effectiveness [4]. The footer names the company as Wellness MD Group PC DBA PeRx; we found no street address on the pages we read [4].

A prescription does not make a product legal to compound. Most of PeRx's menu sits outside FDA's Category 1 and the 503A bulks list [1] [2]. Under our rating rule, a live problem on the site today moves a company to Avoid, and we treat selling peptides that cannot be lawfully compounded that way. Our peptide FDA status tracker has the full status of each one.

Peptides on PeRx's menu and whether a 503A pharmacy may compound them, checked Oct 24, 2026
On PeRx's menuLegal to compound today?WhySources
BPC-157 (injectable and capsules), BPC/TB-500NoNot on the bulks list or in Category 1; July 2026 committee votes are not binding and FDA has not acted[1] [2] [11] [6]
CJC-1295 / ipamorelin, tesamorelin / ipamorelinNoThe committee voted against CJC-1295 in December 2024; ipamorelin is not on the bulks list[1] [12] [2]
Thymosin alpha-1NoThe committee voted against it in December 2024[1] [12]
MOTS-c, epitalon, SemaxNoFavorable but nonbinding July 2026 votes; FDA has not acted[1] [11] [13]
Selank (in Semax/Selank and a three-peptide blend)NoListed by FDA as nominated but withdrawn, which does not allow compounding[1] [5]
DSIPNoThe committee voted against it on July 24, 2026[1] [13]
KLOWNoA blend reported to contain GHK-Cu, BPC-157, TB-500 and KPV, none legal to compound for injection; see our KLOW page[1] [2]
GHK-Cu (form not stated on the menu)Injectable: no. Cream or other non-injectable: yesNon-injectable forms are in Category 1; injectable GHK-Cu may not be compounded[1] [2]
NAD+, glutathioneYes, with a prescriptionCategory 1[1] [2]
Sermorelin, PT-141, SS-31Not confirmedWe found no clear FDA statement either way[1]
AOD 9604 products were marked "Unavailable" on PeRx's page when we checked [1]. The committee voted against AOD-9604 in December 2024 [12].

No interim policy is in force yet

An HHS and FDA "Interim Access Policy for Compounding Using Certain Peptides" was sent for White House review in mid-October 2026 and has not been issued; its text is not public [6] [7]. Review meetings are scheduled for Oct 21 to Oct 28, 2026 [8]. Committee votes and the pending policy do not, on their own, allow compounding [7].

What PeRx costs

PeRx prices, checked Oct 24, 2026
ProductPriceBillingSource
Compounded semaglutide$249 a monthRenews every 28 days until you cancel; no minimum[3]
Compounded tirzepatide$399 a monthRenews every 28 days until you cancel; no minimum[3]
Peptide protocolsFrom $199Described as per prescription with no auto-renewal, and also as $199 to $349 a month on the same page[3]
PeRx says the provider review, supplies and overnight refrigerated shipping are included [3]. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness or quality.

Prices for peptides that can be legally prescribed are on our legal peptide price tracker. GLP-1 options are compared on tirzepatide online.

FDA, BBB and LegitScript check

  • FDA warning letters: none to PeRx or Wellness MD Group in FDA's database or fda.gov search results, Oct 24, 2026 [9]. FDA's Aug 24, 2026 peptide letters went to research-peptide sellers, not PeRx [10]. See our FDA warning letter tracker.
  • BBB: not checked. bbb.org blocks automated access.
  • LegitScript: not checked. Its lookup needs an interactive form.
  • Trustpilot: we could not load a PeRx profile.

There is no legal way to buy BPC-157, TB-500 or thymosin alpha-1 for human use in the US today; our BPC-157 page explains the rules. For compounded GLP-1s, the company below is rated Clean. Our review list has the rest.

We earn commissions from some partners, which can affect where they appear on this page. It never changes a verdict. How we make money

Clean-rated alternatives for compounded GLP-1s

  1. bmiMD

    Clean

    Good fit for: low-price compounded GLP-1s

    PriceSee our bmiMD review
    What you get
    Compounded GLP-1 programs
    FDA record
    No live warning letter in our review
    BBB
    F; BBB cites 6 unanswered complaints out of 43, Oct 24, 2026 [14]

    Visit bmiMDon the bmiMD website

  2. Good fit for: visits and medication in one price

    PriceSee our Henry Meds review
    What you get
    Visits and medication in one price
    FDA record
    No live warning letter in our review
    BBB
    F; BBB cites 31 unanswered complaints out of 236, mostly billing, cancellation and fulfillment, Oct 24, 2026 [15]

    Visit Henry Medson the Henry Meds website

  3. Found

    Clean

    Good fit for: compounded, brand and non-GLP-1 options

    PriceSee our Found review
    What you get
    Compounded semaglutide and tirzepatide, brand GLP-1s and non-GLP-1 options
    FDA record
    No warning letter found in our review
    BBB
    See review

    Visit Foundon the Found website

Questions people ask

Is PeRx legit?

PeRx is a real telehealth brand of Wellness MD Group PC, but we rate it Avoid because it sells BPC-157, TB-500, CJC-1295/ipamorelin, thymosin alpha-1 and other peptides that FDA's lists do not allow a 503A pharmacy to compound, as of Oct 24, 2026 [1] [2].

How much does PeRx cost?

PeRx lists compounded semaglutide at $249 a month and compounded tirzepatide at $399 a month, renewing every 28 days, and peptide protocols from $199, checked Oct 24, 2026 [3].

Does PeRx require a prescription?

Yes. PeRx says prescriptions are issued only after an online consultation with an independent licensed provider [1].

Does PeRx have an FDA warning letter?

We found none. FDA's warning letter database and fda.gov search showed no letter to PeRx or Wellness MD Group as of Oct 24, 2026 [9].

Is PeRx's BPC-157 legal?

No. BPC-157 is not on the 503A bulks list or in Category 1, so a 503A pharmacy may not compound it [2]. The July 23, 2026 advisory vote in its favor is not binding, and FDA had not acted as of Oct 24, 2026 [11] [7].

Who owns PeRx?

The footer of PeRx's site names the company as Wellness MD Group PC DBA PeRx [4].

Medical review: pending. A licensed clinician has not yet reviewed this page.

Sources

15 cited
  1. PeRx home page and peptide menu. PeRx (Wellness MD Group PC), Oct 24, 2026.
  2. Bulk drug substances nominated for use in compounding under section 503A (categories document). FDA, May 14, 2026.
  3. PeRx pricing. PeRx, Oct 24, 2026.
  4. BPC-157. PeRx, Oct 24, 2026.
  5. Certain bulk drug substances for use in compounding that may present significant safety risks. FDA, Apr 22, 2026.
  6. Peptides at a crossroads: what wellness providers need to know. Holland & Knight, Oct 16, 2026.
  7. FDA submits interim peptide compounding policy for White House review: what pharmacies should know. Buchanan Ingersoll & Rooney, Oct 16, 2026.
  8. EO 12866 meetings: Interim Access Policy for Compounding Using Certain Peptides (RIN 0910-ZD94). Office of Information and Regulatory Affairs (reginfo.gov), Oct 24, 2026.
  9. Warning letters database. FDA, Oct 24, 2026.
  10. FDA balances peptide policy with enforcement against unlawful peptide sellers. Sheppard Mullin (FDA Law Update), Sep 18, 2026.
  11. Bulk list bound: PCAC backs majority of peptides in two-day public meeting. McDermott Will & Emery, Jul 27, 2026.
  12. PCAC final summary minutes, Dec 4, 2024. FDA, Dec 4, 2024.
  13. The peptide wave rolls on: PCAC adds two more bulk drug substances for the 503A list. Hyman, Phelps & McNamara (FDA Law Blog), Jul 24, 2026.
  14. bmiMD (MEDCCM, Inc.) business profile. Better Business Bureau, Oct 24, 2026.
  15. Henry Meds business profile. Better Business Bureau, Oct 24, 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Check a peptide's FDA status